Prevalence and Management of Chronic Non-Communicable Diseases in Adult Patients

Abstract

Background. Chronic non-communicable diseases (NCDs)—principally cardiovascular disease, cancer, chronic respiratory disease, and diabetes mellitus—are the leading cause of death and disability worldwide, accounting for roughly three-quarters of all deaths. Their rising prevalence among adults, driven by ageing populations and modifiable behavioural and metabolic risk factors, poses a defining challenge for health systems.

Objective. To synthesise current evidence on the prevalence, burden, risk factors, and management of the major chronic NCDs in adult patients, with emphasis on cost-effective, scalable approaches to prevention and care.

Methods. We conducted a structured narrative review of peer-reviewed literature, World Health Organization (WHO) surveillance and policy documents, and international epidemiological data, prioritising guideline-level evidence and large datasets.

Results. NCDs cause approximately 41 million deaths annually (around 74% of global mortality); cardiovascular diseases account for the largest share (around 17.9 million deaths), followed by cancers (around 9.3 million), chronic respiratory diseases (around 4.1 million), and diabetes (around 2.0 million). About 77% of NCD deaths and 86% of premature NCD deaths occur in low- and middle-income countries. Four shared behavioural and metabolic risk factors—tobacco use, harmful alcohol use, unhealthy diet, and physical inactivity, operating through raised blood pressure, obesity, hyperglycaemia, and dyslipidaemia—drive most disease. WHO has identified a set of cost-effective “Best Buy” interventions whose full implementation could, by 2030, save an estimated 12 million lives at a cost of around US$3 per person per year.

Conclusion. Most NCD burden in adults is preventable or manageable through known interventions. The central challenge is implementation—integrating cost-effective prevention and primary-care management, particularly of hypertension and diabetes, within a multisectoral, whole-of-society response.